327 related articles for article (PubMed ID: 11070010)
1. Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.
Geiss BJ; Smith TJ; Leib DA; Morrison LA
J Virol; 2000 Dec; 74(23):11137-44. PubMed ID: 11070010
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
Keadle TL; Morrison LA; Morris JL; Pepose JS; Stuart PM
J Virol; 2002 Apr; 76(8):3615-25. PubMed ID: 11907201
[TBL] [Abstract][Full Text] [Related]
4. ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice.
Korom M; Wang H; Bernier KM; Geiss BJ; Morrison LA
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515256
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.
Smith TJ; Ackland-Berglund CE; Leib DA
J Virol; 2000 Apr; 74(8):3598-604. PubMed ID: 10729135
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants.
Smith TJ; Morrison LA; Leib DA
J Virol; 2002 Mar; 76(5):2054-61. PubMed ID: 11836383
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
Murphy JA; Duerst RJ; Smith TJ; Morrison LA
J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
[TBL] [Abstract][Full Text] [Related]
9. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.
Reszka NJ; Dudek T; Knipe DM
Vaccine; 2010 Mar; 28(15):2754-62. PubMed ID: 20117270
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.
Morrison LA; Knipe DM
Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391
[TBL] [Abstract][Full Text] [Related]
11. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
Morrison LA; Knipe DM
J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
[TBL] [Abstract][Full Text] [Related]
12. The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle.
Strelow L; Smith T; Leib D
Virology; 1997 Apr; 231(1):28-34. PubMed ID: 9143299
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice.
Keadle TL; Laycock KA; Morris JL; Leib DA; Morrison LA; Pepose JS; Stuart PM
J Gen Virol; 2002 Oct; 83(Pt 10):2361-2365. PubMed ID: 12237416
[TBL] [Abstract][Full Text] [Related]
14. B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease.
Schrimpf JE; Tu EM; Wang H; Wong YM; Morrison LA
PLoS One; 2011; 6(8):e22772. PubMed ID: 21826207
[TBL] [Abstract][Full Text] [Related]
15. Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function.
Walker J; Leib DA
Vaccine; 1998 Jan; 16(1):1-5. PubMed ID: 9607001
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
17. Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice.
Korom M; Wylie KM; Morrison LA
J Virol; 2008 Apr; 82(7):3642-53. PubMed ID: 18234805
[TBL] [Abstract][Full Text] [Related]
18. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness.
Duerst RJ; Morrison LA
Virology; 2004 Apr; 322(1):158-67. PubMed ID: 15063125
[TBL] [Abstract][Full Text] [Related]
20. The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.
Cotter CR; Kim WK; Nguyen ML; Yount JS; López CB; Blaho JA; Moran TM
J Virol; 2011 Dec; 85(23):12662-72. PubMed ID: 21937652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
